PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9495681::ACT053909

Ctn_15_34_retroenantio

Evidence text

Paper-level observation

Section 3.3: versus 191 μM and 43 μM for Ctn[15-34] enantio and Ctn[15-34] retroenantio
textConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
other
Comparator
=
Raw observation
43 µM
Normalized measurement
=43 µM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
1BR3G
Assay method
Not reported by source
Sequence
FPITVGIVMPKKFIKKLRKK
Standardization
ready simple

Source publication

Examining Topoisomers of a Snake-Venom-Derived Peptide for Improved Antimicrobial and Antitumoral Properties.

Biomedicines · 2022

DOI 10.3390/biomedicines10092110 PMC9495681
Parent mention

Related peptide identities

PEPDIA-PLP-000777

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.